Morphine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Morphine and local guidelines before prescribing.

Opioid analgesic

Mechanism

Mu-opioid receptor agonist.

Uses

Severe pain, acute pulmonary oedema (selected), palliative breathlessness, MI analgesia.

Dosing

4 more dose entries from the chapters
  • Immediate-release morphine (e.g. oral solution) 2.5–5 mg every 4 hours as needed , then convert to regular dosing; or
    Palliative: Symptoms Management
  • Modified-release morphine 10–15 mg twice daily , plus immediate-release morphine for breakthrough pain.
    Palliative: Symptoms Management
  • Pain or breathlessness | Morphine 2–5 mg SC hourly as needed (opioid-naive), or 1/6 of the 24-hour SC dose if already on opioids. eGFR under 30 - oxycodone 1–2 mg SC or alfentanil (specialist advice)
    Palliative: End of Life Care
  • From oral morphine: Divide the 24-hour total by 2 for SC morphine (e.g. MR morphine 30 mg twice daily = 60 mg a day oral = 30 mg SC over 24 hours ).
    Palliative: End of Life Care

Side effects

Constipation, nausea, drowsiness, respiratory depression, itching, hypotension; metabolites accumulate in renal failure.

Interactions

Benzodiazepines, alcohol and CNS depressants; MAOIs.

Contraindications and cautions

Respiratory depression, raised intracranial pressure

Monitoring

Pain scores, respiratory rate, sedation

Pregnancy and breastfeeding

Avoid prolonged use

Renal and hepatic impairment

Active metabolites accumulate in renal failure

Overdose and reversal

Naloxone

Special advice

Co-prescribe laxatives; prefer alternatives (oxycodone) in renal impairment; titrate cautiously; naloxone for toxicity.

More from the textbook: uses, cautions and other points
Where it is discussed in the book